Max Healthcare Institute Limited
Max Healthcare Institute Limited operates in Hospital, part of the Healthcare sector. It booked ₹2,569 cr of revenue in its latest quarter (Q2 FY27) and kept 16.2% of sales as profit. It is the 2nd largest of 9 Hospital companies we track, by market value.
Healthier than 55% of companies in Healthcare, on all six measures of filed financials. Each measure is ranked against the 80–153 companies that reported it.
Measures financial condition, not whether to buy. Learn what this score means · How this is calculated
- RSI (14)
- 51
At close. Not part of the score.
How much profit it earns on the money it employs
How much it owes, and whether earnings cover the interest
Whether reported profit actually arrives as cash
Whether sales and profit have grown, and how steadily
What today's price implies, against our models or its peers
How much of the promoters' stake is pledged, and how much they hold
What if I invest in MAXHEALTH?
Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.
The starting rate is a round number, not a view on this company — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.
P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-11-04.
An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.
| Revenue from Operations | ₹2,569 cr |
| Other Income | ₹41 cr |
| Total Income | ₹2,610 cr |
| Cost of Materials | ₹0 cr |
| Purchases of Stock-in-Trade | ₹522 cr |
| Inventory Change (±) | ₹-7 cr |
| Employee Benefit Expense | ₹399 cr |
| Finance Costs | ₹74 cr |
| Depreciation & Amortisation | ₹138 cr |
| Other Expenses | ₹943 cr |
| Total Expenses | ₹2,069 cr |
| Profit before Tax | ₹541 cr |
| Tax Expense | ₹126 cr |
| Net Profit | ₹414 cr |
| Net margin on total income | 15.9% |
| Metric | Q4 FY26 | Q1 FY27 | Q2 FY27 |
|---|---|---|---|
| Revenue | 2,143 cr | 2,366 cr | 2,569 cr |
| Total income | 2,191 cr | 2,407 cr | 2,610 cr |
| Expenses | 1,726 cr | 1,970 cr | 2,069 cr |
| Profit before tax | 465 cr | 436 cr | 541 cr |
| Tax | 122 cr | 113 cr | 126 cr |
| Net profit (owners' share) | 342 cr | 323 cr | 415 cr |
| Net margin (owners' share, on revenue) | 16.0% | 13.6% | 16.2% |
| EPS (₹) | 3.52 | 3.32 | 4.26 |
| Company | Price | Market cap | P/E | ROE | Net margin | 1-yr return |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹8,440 | ₹1.21 L cr | 52.2 | 24.5% | 8.2% | — |
| Max Healthcare Institute Limitedthis company | ₹896 | ₹87,160 cr | 52.6 | 14.6% | 16.2% | — |
| Manipal Health Enterprises Limited | ₹642 | ₹75,740 cr | 81.9 | — | 7.5% | — |
| Fortis Healthcare Limited | ₹786 | ₹59,306 cr | 55.6 | 10.8% | 10.5% | — |
| Narayana Hrudayalaya Ltd. | ₹1,871 | ₹38,228 cr | 31.6 | 24.1% | 10.6% | — |
| Global Health Limited | ₹1,326 | ₹35,621 cr | 40.4 | 20.3% | 14.9% | — |
| Aster DM Quality Care Limited | ₹681 | ₹35,303 cr | 549.5 | 1.4% | 1.2% | — |
| Krishna Institute of Medical Sciences Limited | ₹731 | ₹30,681 cr | 175.6 | 7.4% | 3.5% | — |
| Dr. Agarwal's Health Care Limited | ₹513 | ₹16,256 cr | 89.7 | 8.9% | 7.4% | — |
| Action | Detail | Ex-date |
|---|---|---|
| Dividend | ₹2 / share | 3 Jul 2026 |
| Dividend | ₹1.5 / share | 4 Jul 2025 |
| Dividend | ₹1.5 / share | 23 Aug 2024 |
| Dividend | ₹1 / share | 8 Sep 2023 |
A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.
Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.
Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.
The company also transacted with 9 other related parties — subsidiaries, joint ventures, directors and others — that we could not match by name to the promoter list above. Some may still be connected to the family; we only count the ones the filings let us match with certainty.
Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.